Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome
Brain
.
2021 Jun 22;144(5):e44.
doi: 10.1093/brain/awab069.
Authors
Matteo Foschi
1
,
Lucio D'Anna
2
3
,
Ahmed Abdelhak
4
5
,
Benjamin Mayer
6
,
Hayrettin Tumani
5
7
,
Markus Otto
5
,
Samir Abu-Rumeileh
5
Affiliations
1
Neurology Unit, S. Maria delle Croci Hospital-AUSL Romagna, Ravenna, Italy.
2
Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
3
Department of Brain Sciences, Imperial College London, London, UK.
4
Department of Neurology, University of California San Francisco (UCSF), San Francisco, USA.
5
Department of Neurology, Ulm University Hospital, Ulm, Germany.
6
Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
7
Fachklinik für Neurologie Dietenbronn, Schwendi, Germany.
PMID:
33822000
PMCID:
PMC8083498
DOI:
10.1093/brain/awab069
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Guillain-Barre Syndrome*
Humans
Longitudinal Studies
SARS-CoV-2